VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,815 | +28.7% | 289,240 | -27.3% | 0.00% | 0.0% |
| Q4 2022 | $3,742 | -94.6% | 398,093 | +1456.0% | 0.00% | – |
| Q3 2022 | $69,000 | +43.8% | 25,585 | +58.6% | 0.00% | – |
| Q1 2022 | $48,000 | -65.5% | 16,133 | -46.9% | 0.00% | – |
| Q4 2021 | $139,000 | +531.8% | 30,400 | +533.5% | 0.00% | – |
| Q1 2020 | $22,000 | -65.1% | 4,799 | -39.8% | 0.00% | – |
| Q4 2019 | $63,000 | -86.4% | 7,968 | -88.2% | 0.00% | -100.0% |
| Q3 2019 | $463,000 | +382.3% | 67,411 | +481.5% | 0.00% | – |
| Q2 2019 | $96,000 | +33.3% | 11,593 | +21.6% | 0.00% | – |
| Q4 2018 | $72,000 | -93.4% | 9,534 | -84.7% | 0.00% | -100.0% |
| Q3 2018 | $1,086,000 | +670.2% | 62,358 | +317.0% | 0.00% | +200.0% |
| Q2 2018 | $141,000 | +314.7% | 14,954 | +91.8% | 0.00% | 0.0% |
| Q1 2018 | $34,000 | – | 7,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
| Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
| Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
| Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
| Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
| DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
| 5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
| Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |